Navigation Links
Group in Medical Technology

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... the mean percent change in the Forteo(R) group for lumbar spine BMD was 5.5 percent, and for ... months compared with 8.6 percent in the Forteo(R) group and boosted femoral neck BMD by 4.1 percent ... patients enter long-term care, and half of this group never returns to living independently. ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... baseline to the end of the study in the trazodone group versus the placebo group. Statistical ... showed statistical significance in favor of the group administered Labopharm's trazodone. In addition, ... The drop out rate was 21 percent in the placebo group and 30 percent in the trazodone group. In the ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

... August 4 /PRNewswire/ -- Debiopharm group (Debiopharm), a Swiss-based global ... and physical inactivity. About Debiopharm group Debiopharm group is a Swiss-based global ...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

... risk of breast cancer." Estrogens are a group of hormones that play a key role in regulating ... found no obvious skin benefits in this particular group of women, another study that looked at women who ... did not wait to start treatment like the other group -- did experience noticeable improvements in ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... respond to at least one biologic treatment, the group treated with R788 (fostamatinib disodium) did not ... ACR 70 and DAS28 response rates than the placebo group at three months, and therefore, the trial failed ... to placebo. Although the ACR scores for the R788 group were within the expected range in this patient ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... returned to normal. About Debiopharm group Debiopharm group is a Swiss-based global ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... returned to normal. About Debiopharm group Debiopharm group is a Swiss-based global ...

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

... levels decreased from baseline in the nevirapine group 0.2 mg/dL and increased 28.1 mg/dL in the ATV/r group (p <0.0001). Mean increases in LDL cholesterol were 15 mg/dL in the nevirapine group and 10.5 mg/dL in the ...

Iontophoretic Drug Delivery System (IDDS) Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in a Phase 2 Clinical Trial

... Seattle, WA (a subsidiary of the Transcu group Limited, a company listed on the Singapore ... statistically lower VAS scores for the Active group as compared to the Placebo group. In addition, more than 80% of the Active group reported pain elimination and willingness to ...

Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story

... Oncology Group, an NCI-sponsored cooperative group headquartered at the University of Michigan . ... Control and Prevention for the Southwest Oncology group and director of the University of ... John Crowley, Ph.D., of the Southwest Oncology group Statistical Center and Charles A. Coltman, M.D., ...

Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet

... and medically significant conditions in the group vaccinated with Cervarix (R) were similar to the ... who received at least one vaccine dose. This group comprised a diverse population of women including ... is a registered trademark of the GlaxoSmithKline group of companies. Cautionary statement ...

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

... $7.5m Milestones for Both Companies Sosei group Corporation ("Sosei"; TSE Mothers Index: 4565) ... agreement with Novartis Sosei and Vectura group plc concluded a global development ... new products. About Sosei Sosei group is a leading international biopharmaceutical ...

Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative

... A Commonwealth Fund case study notes that group Health Cooperative is structured with ... Hill in cooperative structures, pointing to group Health as a "shining example" of the model, while ... create better health care, medical systems like group Health that have pioneered a different approach, ...

Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries

... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... also fewer side effects. About Debiopharm group Debiopharm group is a Swiss-based global ...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... in two different types of packaging: one group received their drugs in standard pharmacy vials, while the other group was given the exact same drug in a unit dose ... both groups, OSU researchers found that the group who received their drugs in blister packs with ...

Scottsdale Facility to Be First in U.S. to Showcase True REST Technology

... sober and drug-free. None of the control group did so for eight months of follow-up. ... 22 percent of the participants in the floating group were entirely pain-free, and 56 percent ... session, monthly, twice a month or weekly rates. group rates are available upon request. Reservations ...

Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)

... patients of the placebo group, 55.3% of the 120 U group and 46.0% of the 240 U group. AEs reported most ... of the placebo group, in 58.1% of the 120 U group and in 71.0% of the 240 U group. AEs reported ... is the wholly owned, US subsidiary of the Merz group of Companies. A specialty pharmaceutical company, ...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

... design (e.g., endpoints, sample size, control group and statistical analyses) is acceptable to ... with only 5 patient (8%) deaths in the orBec(R) group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139). At one year post randomization ...

Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting

... in the BTXCo group, and 22.7% in the placebo group reported an adverse event. There were no ... (1.6%) were randomized to the 50 U/mL dilution group (95 patients) or to the 20 U/mL dilution group (97 patients). Limb position (60.4%), Dressing ...

Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain and Hypoglycemia Risk for Diabetes Patients

... challenge was significantly lower in the TI+G group (37 vs. 54 mg/dL; p<0.0001). TI+G produced ... with AFRESA than with RAA. Patients in the AFRESA group lost weight (-0.5 +/- 0.3), while patients in the RAA group gained weight (+1.4 +/- 0.3), with the difference ...

New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar

... a multicenter, randomized, open-label, parallel group study in insulin naive patients. Lantus(R) was ... achieving A1C<7% at week 24 was greater in the group receiving Apidra(R) three times daily (45.1%) versus the group receiving Apidra(R) one time daily (29.7%, ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... a significantly greater extent in the lorcaserin group than the placebo group at Week 52. "We are pleased to present the ... 5% of baseline body weight in the active-product group is at least 35%, is approximately double the ...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... statistically significantly better in the patient group randomized to Avandia after the average of 5.5 ... rates of CHF in RECORD were higher in the group randomized to Avandia (61 events or 2.7 percent ... bone fractures, which were higher in the group randomized to Avandia and were seen mostly in the ...

Top Medical Research Centers Form Velos Advisory Group for Service-Oriented Architecture

... instrumental in establishing a Velos Advisory group for Service-Oriented Architecture (SOA). Five ... and UT Southwestern Medical Center. The Advisory group will collaborate with Velos to create an SOA ... "We are pleased at the formation of this Advisory group and gratified to see institutions of such high ...

PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference

... 70-point response was 61 percent in the 500 mg QD group versus 47 percent for placebo (p=0.039). ... to 100-point response was 55 percent in this group versus 40 percent for placebo (p=0.029). In his ... of Severity (CDEIS) was observed in the 500 mg QD group compared to placebo (CDEIS decrease of -8.4 vs. ...

Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

... + placebo were as follows: group SD > 12 ... with results as follows: group Median Overall Survival* % ... in the perifosine + capecitabine patient group is ongoing with 10 of the 20 patients in ...

Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables

... 60 days, 3% of patients in the relaxin-30 group had been rehospitalized for heart failure and no ... causes, as compared to 17% in the placebo group (p=0.06), a greater than 80% reduction. After an ... months, no patients in the relaxin-30 group had died of cardiovascular causes, as compared to ...

Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

... capecitabine + placebo were as follows: group N CR PR ORR SD > 12 ... with results as follows: group Median Overall Survival* ... in the perifosine + capecitabine patient group is ongoing with 10 of the 20 patients in this arm ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

... and Zoloft(R) (sertraline), and are among a group of drugs known as CYP2D6 inhibitors. ... but was not limited to antidepressants, and a group of 945 women on tamoxifen who were not taking any ... the cohorts using a CYP2D6 inhibitor and the group on tamoxifen only. The study found that women ...

Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer

... -- The Spanish Head and Neck Cancer Cooperative group (TTCC) announced today that Induction ... die from the disease. Head and neck cancer is a group of tumors that mostly arise in the cells that ... is a Spanish non-profit scientific cooperative group fully devoted to head and neck cancer. ...

Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer

... agent perifosine was as follows: group N PR SD > 12 wks CBR* ... agent perifosine was as follows: group N PR SD > 12 wks CBR ... (11.7, 33.6)] Three patients out of the group of patients previously treated with and failed ...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

... for high-risk neuroblastoma: Children's Oncology group (COG) study ANBL0032 Lead investigator: A. L. Yu, Children's Oncology group Abstract 10067z, Oral Presentation, ... current assumptions and forecasts made by Bayer group management. Various known and unknown risks, ...

Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013

... in Europe , according to Millennium Research group WALTHAM, Mass., May 28 /PRNewswire/ -- ... and many more. About Millennium Research group Millennium Research group ( www.MRG.net ), a Decision Resources, Inc. ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... Sandostatin LAR versus 7.2 months in the placebo group (P<0.0001)(1). The trial, called PROMID ( ... enrolled in the independent Breast International group (BIG) 1-98 study (Femara(R) [letrozole tablets] ... Results from this study revealed that the group of patients receiving Femara had clinically and ...

Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia

... (median change 0.3 kg for overall lurasidone group vs. 0 kg for placebo) as was its effect on lipid ... (6% and 2% for the overall lurasidone group and placebo, respectively). Adverse events ... six-week study duration for each lurasidone dose group vs. placebo. A key secondary endpoint was the ...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... of the Genting Group. Over the years, the Asiatic group had embarked on several significant acquisitions ... in line with its long term strategy, the Asiatic group had, in June 2005, further expanded its ... to develop some 98,300 hectares. The Asiatic group also owns 5 oil mills with a total milling ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... decrease in FVC at week 72 in the pirfenidone group than in the placebo group. This magnitude of ... In addition, 40% more patients in the pirfenidone group did not experience a decline in percent predicted ... the ATS meeting data on the low-dose pirfenidone group for the efficacy outcome measures of change in ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... months for patients in the RISPERDAL(R) CONSTA(R) group and five months for patients in the placebo ... among patients in the RISPERDAL(R) CONSTA(R) group (30 percent; 42/140) compared with the placebo group (56 percent; 76/135). The median dose of ...

Mutant Genes in High-Risk Childhood Leukemias Identified

... Research Hospital, the Children's Oncology group (COG), the University of New Mexico Cancer ... for a cure. The problem is that this high-risk group is likely a heterogeneous mixture of biologic ... COG, an international clinical trial cooperative group supported by the NCI. Other authors of the ...

Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms

... Problem Subscale of the NYPRS-S in the INTUNIV group compared to placebo (-16.0 vs -9.6; P< .001). ... interactions. On the PSI/SF scale, the INTUNIV group reduced its score by 17.0 compared to 7.7 for the placebo group ( P= .002). "These data are testament to ...
Other Contents
(Date:8/21/2014)... unknown process for harvesting energy and producing oxygen from ... University scientist has discovered. The discovery lays the foundation ... energy from the Sun, and understanding dense blooms like ... worldwide. A paper describing the discovery will be published ... journal Science on 21 August 2014. , ...
(Date:8/21/2014)... aimed at improving the food intake, health and quality ... is among three projects at the University of Waterloo ... Canadian Institutes of Health Research (CIHR). , Professor ... at Waterloo, and a Schlegel research chair in nutrition ... investigate why many Canadians living in long-term care homes ...
(Date:8/21/2014)... Ever heard of the water window? It consists of ... are not absorbed by the water in biological tissues. ... develop coherent radiations within the water window. These could ... a high-contrast image of the biological samples or to ... study identifies the physical mechanism needed to efficiently generate ...
Breaking Biology News(10 mins):Hot-spring bacteria reveal ability to use far-red light for photosynthesis 2Hot-spring bacteria reveal ability to use far-red light for photosynthesis 3Grants will fund landmark aging research at Waterloo 2Water window imaging opportunity 2
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... content that is written by marketing experts for marketers ... affiliate links has caught the attention of Shane Michaels, ... involved with Internet marketing in any way knows that ... failure in the industry,” reports Michaels. “But even though ...
(Date:8/22/2014)... Buying a policy for different life insurance products can ... coverage types by insurers in the U.S. The Quotes Pros ... the public using its sortable tool at http://quotespros.com/life-insurance.html . ... is expected to promote the discounts and special offerings for ... The system is designed to help an adult locate a ...
(Date:8/22/2014)... 2014 Millennium Treatment Group has recently noticed ... high level of drug use among teenagers. The treatment facility ... addiction and work to minimize drug abuse. , America is ... drug addiction in history. According to the National Institute ... Americans aged 12 or older—or 9.2 percent of the population—had ...
(Date:8/22/2014)... Amy Norton HealthDay ... -- A growing number of Americans on work disability ... study. Researchers found that between 2007 and 2011, ... Insurance benefits were prescribed narcotic painkillers each year. And ... percent in 2007 to 23 percent in 2011. ...
(Date:8/22/2014)... Many Americans know little about how Ebola is transmitted and ... the United States, a new survey shows. About four ... be a major Ebola outbreak in the United States, and ... will get sick with the deadly virus in the next ... poll. However, those opinions don,t match reality, the Harvard ...
Breaking Medicine News(10 mins):Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2
Other TagsOther Tags